13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE 13D/A Filed 2026-08-28 Event 2026-08-18 SEC 0000897069-26-001732 →

Bianco James A. TuHURA Biosciences, Inc. HURA

Stake: 4.60% Shares: 3,085,519 CUSIP: 898920103 Class: Common Stock, par value $0.001 per share

Item 4 — Purpose of Transaction

Item 4 of the Original Schedule 13D is hereby amended and supplemented to add the following: As described in Item 5, as a result of the issuance by the Issuer of additional shares of Common Stock, and not as a result of any acquisition or disposition of securities by the Reporting Person, the Reporting Person ceased to be the beneficial owner of more than five percent of the outstanding Common Stock on August 18, 2026. Accordingly, this Amendment constitutes the final amendment to the Schedule 13D, and the Reporting Person's reporting obligations under Section 13(d) of the Act with respect to the Common Stock are terminated. The Reporting Person continues to serve as the President and Chief Executive Officer and a director of the Issuer.

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
2 13D/G filings on this issuer
1 other filing besides this one
Filer Track Record
1 filings by this filer
0 other filings in the data moat
Short Interest · settle 2026-08-14
DTC 20.97
6,323,340 shares short · -2.8% vs prior

Other 13D/G Filings on TuHURA Biosciences, Inc.

FiledFormFilerStakeShares
2018-01-08 SC SABBY MANAGEMENT, LLC view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →